FDA Inspection 1171520 — Roswell Park Cancer Institute
The FDA completed an inspection of Roswell Park Cancer Institute on May 6, 2022 in Buffalo, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 6, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Buffalo, NY (United States)
Additional Details
Sponsor, Contract Research Organization